Condition: Venous Embolism of Lower Extremities (Diagnosis) · Arterial Embolism and Thrombosis · Acute DVT of Lower Extremity · Sponsor: Medtronic Endovascular
The purpose of Case-Specific Health Care Professional (HCP) Clinical Survey of Liberant™ Thrombectomy System, also known as the Liberant Clinical Assessment, is to collect first-in-human clinical data to confirm the safety and performance of the Medtronic Liberant™ thrombectomy system when used for the removal of fresh, soft emboli or thrombi from the vessels of the peripheral arterial and venous systems
This description comes directly from the study's public registry record.
Manasa Gudipally · 763-514-4000 · manasa.gudipally@medtronic.com
Elizabeth Hunt · elizabeth.m.hunt@medtronic.com
Always discuss trial participation with your own doctor first.
| MedStar Health | Washington D.C., District of Columbia, United States | Recruiting |
| Naples Comprehensive Health | Naples, Florida, United States | Recruiting |
| Mount Sinai | New York, New York, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07335341